BNET Industries

Cyberkinetics Neurotechnology Systems Inc.

(CYKN) is in the Business Services Industry

Market Cap:$693.0K
Last Fiscal Year Sales:$2.2M
  • Public
  • US
Dow Jones Description

Cyberkinetics Neurotechnology Systems, Inc., a leader in the neurotechnology industry, is developing neural stimulation, sensing and processing technology to improve the lives of those with severe paralysis resulting from spinal cord injuries, neurological disorders and other conditions of the nervous system. Cyberkinetics' product development pipeline includes: the FDA cleared-to-market NeuroPort? System, a neural monitor designed for acute inpatient applications and labeled for temporary (less than 30 days) recording and monitoring of brain electrical activity; the Andara? Oscillating Field Stimulator? (OFS) Device, an investigative device designed to stimulate regeneration of the neural tissue surrounding the spinal cord; and the BrainGate System, an investigative device designed to provide communication and control of a computer, assistive devices, and, ultimately, limb movement.

Board of Directors
John P. Donoghue
Contact Information

100 Foxborough Boulevard

Suite 240

Foxborough, Massachusetts 02035

www.cyberkineti...

508-549-9981

NAICS Code Research and Development in the Social Sciences and Humanities: 541720

Recent Events

  • NeuroMetrix and Cyberkinetics Form Joint Venture to Develop AndaraTM OFSTM Therapy for Peripheral Nerve Injury

    2/19/08 - Joint Venture / Alliance - View Story

  • Cyberkinetics teams up with neurology partner

    11/24/07 - Joint Venture / Alliance - View Story

  • Cyberkinetics and NeuroMetrix Forge Strategic Alliance and Agree to Pursue Joint Venture Aimed at Developing...

    11/14/07 - Joint Venture / Alliance - View Story

  • NeuroMetrix Announces Strategic Alliance with Cyberkinetics

    11/14/07 - Merger / Acquisition - View Story

  • OTCPicks.com: Daily Market Movers Digest Report for Friday August 10th, ACUS, UVSE, ARSC, CYKN, MTTG

    8/10/07 - Financial Announcement - View Story

  • Cyberkinetics Announces Results for the First Quarter Ended March 31, 2007

    5/10/07 - Financial Announcement - View Story

  • Cyberkinetics Announces Results for the Fourth Quarter and Fiscal Year Ended December 31, 2006

    3/20/07 - Financial Announcement - View Story

  • Kurt H. Kruger Joins Cyberkinetics as Chief Financial Officer

    9/19/06 - Mgmt. Change - Entering - View Story

  • Cyberkinetics Announces Second Quarter 2006 Results

    8/07/06 - Joint Venture / Alliance - View Story

  • Cyberkinetics and Minnetronix Finalize Design and Manufacturing Agreement for the AndaraTM OFS Device to Treat...

    6/01/06 - Joint Venture / Alliance - View Story

News & Analysis

Filter by

computer and cyberkinetics neurotechnology systems inc. and productivity - All News and Analysis

Decision Makers

Name (plus bio) Position
Kurt H. Kruger CFO
J. Christophe Flaherty Executive Vice President, Technology and Intellectual Property
Mark A. Carney Executive Vice President
Kimi E. Iguchi Vice President, Finance
Mark P Carthy

Board of Directors

Name (plus bio) Position
John P. Donoghue Board of Directors

Organization Position Status
Oxford Bioscience Partners Chief Scientific Officer, Director Current
Cyberkinetics Neurotechnology Systems, Inc. Founder and Chief Scientific Officer Current
Cyberkinetics Neurotechnology Systems, Inc. Board of Directors Current
Brown University Executive Director Former
Brown University Ph.D. in Neuroscience Former
University of Vermont M.S. in Anatomy Former
Boston University A.B. Former

Organization Position Status
Cyberkinetics Neurotechnology Systems, Inc. CFO Current

Organization Position Status
Cyberkinetics Neurotechnology Systems, Inc. Executive Vice President, Technology and Intellectual Property Current
Viasys Healthcare Inc. Vice President of Engineering and New Technologies Former
Biogen Idec, Inc. Senior Manager of External Reporting Former
Massachusetts Institute of Technology B.S. in Aeronautical and Electrical Engineering Former

Organization Position Status
Cyberkinetics Neurotechnology Systems, Inc. Executive Vice President Current
Cyberkinetics Neurotechnology Systems, Inc. Board of Directors Current

Organization Position Status
Cyberkinetics Neurotechnology Systems, Inc. Vice President, Finance Current
Global Life Science Ventures AG Vice President, Finance Current
Oxford Bioscience Partners Vice President, Finance Current
Millennium Pharmaceuticals, Inc. Senior Director Former
Continental Cablevision Director of Financial Reporting Former
PricewaterhouseCoopers Senior Audit Manager Former
Biogen Idec, Inc. Senior Manager of External Reporting Former
Biogen, Inc. Senior Manager Former
Cooper's Inc. Accountant Former
Northeastern University M.B.A. Former
Drew University B.A. In Chemistry Former

Organization Position Status
Astex Therapeutics Limited Founder of Orion Healthcare Equities Current
Oxford Bioscience Partners General Partner Current
Dynogen Pharmaceuticals, Inc. General Partner, Oxford Bioscience Partners Current
West Membership Co Venture Partner, Oxford Bioscience Partners Current
Cyberkinetics Neurotechnology Systems, Inc. Current
Oxford Bioscience Partners Director Current
Astex Therapeutics Limited Board of Directors Current
Impactrx, Inc. Director Current
Xanthus Pharmaceuticals, Inc. Board of Directors Current
Global Life Science Ventures AG Board of Directors Current
Scion Pharmaceuticals, Inc. Director Current
Xanthus, Inc. Board of Directors Current
Solexa, Inc. Director Current
Salix Pharmaceuticals, Inc. Investor Current
Cubist Pharmaceuticals, Inc. Chief Business Officer Former
Vertex Pharmaceuticals Incorporated Senior Director of Business Development Former
Dendreon Corporation Director Former
Ensemble, LLC Investor Former
Xanthus, Inc. Investor Former
Solexa, Inc. Investor Former
Impactrx, Inc. Investor Former
Harvard Business School Mba Former
University of Missouri M.S. In Chemical Engineering Former
University College Dublin B.E. In Chemical Engineering Former
advertisement
     CYKN $0.01 -0.00 (-12.50% )
Average Volume 16,469
Shares Outstanding 49.50M
Market Cap 346.5K
Year High 0.055
Year Low 0.001
Earnings Per Share N/A
P/E Ratio -
Dividend N/A
Yield N/A
Glass Door

Business Services Industry Companies

Company Employer Rating
PayPal 3.2
FedEx 3.6
Accenture 3.4
Gartner 3.2
UPS 3.1
advertisement